Concepedia

Jeffrey L. Jorgensen

JL

Statistics

Publications

176

Citations

16.6K

H-Index

67

Active since

1985

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Irvine

Baylor College of Medicine

University of California, Irvine Medical Center

Jeffrey L. Jorgensen is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematology.

ORCID

Publications per year

1985–2024

176

Publications

176

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 718 citations · Full text

, , +17

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu et al. · Cancer Discovery · 2018 · 571 citations

, , +17

Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics

Jeffrey L. Jorgensen, Ursula Esser, Barbara Fazekas de St Groth et al. · Nature · 1992 · 519 citations

, , +14

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 504 citations · Full text

, , +17

A human T cell-specific molecule is a member of a new gene family.

Thomas J. Schall, Jan Jongstra, B Dyer et al. · The Journal of Immunology · 1988 · 500 citations

, , +14

1–5 of 176